Affimed Therapeutics
NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
Enterprise value
($12m)
Share price
$0.00 AFMD
Company register number
HRB 721206 (Mannheim)
Authorizing premium user...